% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • boxcarlong boxcarlong Dec 24, 2012 11:08 AM Flag

    MDVN has a $3.5B MKT CAP

    and OGXI has 427 several years away from FDA approval but only a year or two away from proof of concept Postrate, Bladder, ect.........

    If 427 works in Postrate, Bladder, ect via P2 proof of concept trials. I still maintain that the stock is worth mid $30's PPS valuation. Just look at other oncology plays like ARIA. SGEN,

    OGXI has explosive upside potential and we all know as the positive trial data flows the analyst PT's go up up up.

    Merry XMASS to all and buy some REGULUS in 2013


    Sentiment: Strong Buy

0.4699-0.0801(-14.56%)12:53 PMEDT